Is Losing Hair a Side Effect of Ozempic? Understanding the Connection

Last reviewed: July 3, 2026

Last updated: July 3, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide and other GLP-1 receptor agonists have transformed weight loss treatment, but reports of hair loss concern many patients considering therapy. While not listed as a primary side effect in clinical trials, telogen effluvium—a temporary shedding condition triggered by metabolic stress—occurs in some individuals using these medications. PlexusDx provides personalized semaglutide protocols designed to minimize disruption to your body while maximizing sustainable weight loss.

Why Hair Loss Happens During GLP-1 Therapy

Hair loss during semaglutide treatment typically stems from rapid weight loss rather than the medication itself. When the body loses significant weight quickly, it shifts into a catabolic state where hair follicles move prematurely from the growth phase (anagen) into the shedding phase (telogen). This condition, called telogen effluvium, usually resolves within 3 to 6 months as your metabolism stabilizes. The phenomenon is well-documented in any rapid weight loss scenario, including bariatric surgery and calorie restriction.

Nutritional deficiencies amplify hair loss risk during GLP-1 therapy. Reduced food intake and appetite suppression can lower intake of biotin, iron, zinc, and B vitamins—all critical for hair follicle health. Protein insufficiency is particularly concerning, as hair is composed primarily of keratin, a structural protein. Patients on semaglutide who maintain adequate protein and micronutrient intake experience less severe shedding than those with poor dietary quality.

Clinical Evidence on Semaglutide and Hair Shedding

Major clinical trials of semaglutide for weight loss, including the STEP program involving over 4,500 patients, did not formally document hair loss as a side effect. However, real-world patient reports and post-market surveillance data suggest that 5 to 10 percent of users experience noticeable shedding. Most cases are mild to moderate and resolve without intervention once weight stabilizes. Dermatologists recognize this pattern as a predictable consequence of metabolic disruption, not a toxicological effect of the GLP-1 class.

The timeline of hair loss during semaglutide follows a predictable pattern. Shedding typically begins 2 to 4 months after starting therapy, peaks around month 4 to 6, and naturally reverses as your body adapts to its new weight. Early intervention with nutritional support and dose management can reduce severity. PlexusDx clinicians monitor this timeline and adjust treatment protocols to support natural hair growth cycles.

Preventing and Managing Hair Loss on GLP-1 Medications

Adequate protein intake is the single most effective prevention strategy during GLP-1 therapy. Patients should target 100 to 130 grams of protein daily, spread across meals, to supply amino acids needed for keratin synthesis. Plant-based proteins like legumes and nuts, combined with animal sources such as fish and eggs, ensure complete amino acid profiles. Because GLP-1 medications reduce appetite, intentional meal planning becomes essential—passive eating will not meet protein needs.

Micronutrient supplementation addresses the nutritional gaps created by reduced food volume. Iron, biotin, zinc, vitamin B12, and vitamin D support follicle health and are commonly depleted during rapid weight loss. A daily multivitamin formulated for hair health, combined with targeted supplementation based on baseline blood work, reduces shedding risk significantly. Staying hydrated and managing stress through sleep and exercise further stabilizes hormonal pathways that regulate hair growth.

How PlexusDx Personalizes GLP-1 Therapy to Protect Hair Health

PlexusDx offers compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan from licensed 503A compounding pharmacies, with personalized dosing protocols designed to balance rapid weight loss with metabolic stability. Unlike one-size-fits-all approaches, PlexusDx clinicians assess your individual weight loss trajectory and adjust doses to minimize the metabolic shock that triggers telogen effluvium. Slower, steadier weight loss protects hair follicles while still delivering meaningful results.

The Precision Peptide Genetic Test, available for $298, identifies genetic predispositions in peptide pathways that influence how your body responds to semaglutide. Variants in FTO, MC4R, and GIPR genes affect weight loss rate, appetite suppression intensity, and metabolic adaptation. Patients with genetic markers for rapid metabolism receive modified protocols and nutritional guidance to prevent nutrient depletion. This precision approach addresses hair loss at its root—preventing the conditions that trigger shedding rather than treating symptoms after they appear.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Is hair loss a permanent side effect of semaglutide?

No. Hair loss during semaglutide therapy is temporary and typically resolves within 3 to 6 months as your body adjusts to its new weight. The shedding is a consequence of rapid metabolic change, not permanent damage to hair follicles. Maintaining adequate nutrition throughout treatment accelerates recovery.

How much hair loss is normal on GLP-1 medications?

Mild to moderate shedding affecting 5 to 10 percent of users is documented in real-world data, though major clinical trials did not formally measure this outcome. Most patients notice increased hair in the shower or brush rather than visible scalp thinning. Severe hair loss is uncommon and usually indicates nutritional deficiency, which can be corrected with supplementation and dietary adjustment.

Can I prevent hair loss while taking semaglutide?

Yes. Consuming 100 to 130 grams of protein daily, supplementing with biotin, iron, zinc, and B vitamins, and managing stress effectively reduce shedding risk substantially. PlexusDx clinicians provide personalized nutrition guidance and may adjust your dose trajectory to slow weight loss initially, protecting follicle health during the critical adaptation period.

Does compounded semaglutide from PlexusDx cause less hair loss than brand-name Ozempic?

Hair loss risk depends on weight loss rate and nutritional status, not the source of semaglutide. PlexusDx compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan are bioequivalent to branded versions but offer personalized dosing protocols that may actually reduce shedding by slowing initial weight loss. All semaglutide—compounded or branded—carries the same metabolic effects.

How does the Precision Peptide Genetic Test help prevent hair loss?

No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Ozempic For Losing Weight
• Ozempic Side Effects
• Lifemd Ozempic
• Eden Ozempic

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.